Autoantibodies to alpha-synuclein in inherited Parkinson's disease

Journal of Neurochemistry

Volumn 101, Issue 3, 2007, Pages 749-756

  Papachroni, Katerina K ^a   Ninkina, Natalia ^b   Papapanagiotou, Angeliki ^a   Hadjigeorgiou, Georgios M ^c   Xiromerisiou, Georgia ^c   Papadimitriou, Alexandros ^c   Kalofoutis, Anastasios ^a   Buchman, Vladimir L ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF THESSALY   (Greece)

Author keywords

Alpha synuclein; Autoantibody; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; ALPHA SYNUCLEIN ANTIBODY; AUTOANTIBODY; GAMMA SYNUCLEIN; GAMMA SYNUCLEIN ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE TRANSMISSION; FAMILIAL DISEASE; FEMALE; GENETIC DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FAMILY;

AGED; ALPHA-SYNUCLEIN; AUTOANTIBODIES; FAMILY HEALTH; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 34247402084     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04365.x     Document Type: Article

References (29)

1. Bas J., Calopa M., Mestre M., Mollevi D. G., Cutillas B., Ambrosio S. Buendia E. (2001) Lymphocyte population in Parkinson's disease and rat models of parkinsonism. J. Neuroimmunol. 113, 146 152.
2. Benner E. J., Mosley R. L., Destache C. J., Lewis T. B., Jackson-Lewis V., Gorantla S., Nemachek C., Green S. R., Przedborski S. Gendelman H. E. (2004) Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease. Proc. Natl Acad. Sci. USA 101, 9435 9440.
3. Buchman V. L., Hunter H. J. A., Pinon L. G. P., Thompson J., Privalova E. M., Ninkina N. N. Davies A. M. (1998) Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system. J. Neurosci. 18, 9335 9341.
4. Chandra S., Gallardo G., Fernández-Chacón R., Schlüter O. Südhof T. (2005) Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123, 383 396.
5. Chen S., Weidong D. L., Wenjie J. X., Alexianu M. E., Engelhardt J. I., Siklos L. Appel S. H. (1998) Experimental destruction of subtantia nigra initiated by Parkinson's disease immunoglobulins. Arch. Neurol. 55, 1075 1080.
6. Chen A., Zhang B., Hernan M. A., Schwarzschild M. A., Willett W. C., Colditz G. A., Speizer F. E. Ascherio A. (2003) Nonsteroidal anti-inflammatory drugs and the risk of Parkinson's disease. Arch. Neurol. 60, 1059 1064.
7. Defazio G., Dal Toso R., Benvegnu D., Minozzi M. C., Cananzi A. R. Leon A. (1994) Parkinsonian serum carries complement-dependent toxicity for rat mesencephalic dopaminergic neurons in culture. Brain Res. 633, 206 212.
8. Delgado M. Ganea D. (2003) Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation. FASEB J. 17, 944 946.
9. El-Agnaf O. M. A., Salem S. A., Paleologou K. E. et al. (2006) Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease. FASEB J. 20, 419 425.
10. Fiszer U., Mix E., Fredrikson S., Kostulas V., Olsson T. Link H. (1994) Gamma delta+ T cells are increased in patients with Parkinson's disease. J. Neurol. Sci. 121, 39 45.
11. Forman M. S., Lee V. M. Trojanowski J. Q. (2005) Nosology of Parkinson's disease, looking for the way out of a quackmire. Neuron 47, 479 482.
12. Hunot S. Hirsch E. C. (2003) Neuroinflammatory processes in Parkinson's disease. Ann. Neurol. 53, S49 S60.
13. Janus C., Pearson J., McLaurin J. et al. (2000) A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408, 979 982.
14. Lundvig D., Lindersson E. Jensen P. H. (2005) Pathogenic effects of alpha-synuclein aggregation. Brain Res. Mol. Brain Res. 134, 3 17.
15. Luthi-Carter R. (2003) Progress towards a vaccine for Huntington's disease. Mol. Ther. 7, 569 570.
16. Maries E., Dass B., Collier T. J., Kordower J. H. Steece-Collier K. (2003) The role of alpha-synuclein in Parkinson's disease, insights from animal models. Nat. Rev. Neurosci. 4, 727 738.
17. Masliah E., Rockenstein E., Adame A. et al. (2005) Effects of alpha-synuclein immunisation in a mouse model of Parkinson's disease. Neuron 46, 857 868.
18. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I. R. Schwartz M. (1999) Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5, 49 55.
19. Ninkina N. N., Alimova-Kost M. V., Paterson J. W., Delaney L., Cohen B. B., Imreh S., Gnuchev N. V., Davies A. M. Buchman V.L. (1998) Organization, expression and polymorphism of the human persyn gene. Hum. Mol. Genet. 7, 1417 1424.
20. Orr C. F., Rowe D. B., Mizuno Y., Mori H. Halliday G. M. (2005) A possible role for humoral immunity in the pathogenesis of Parkinson's disease. Brain 128, 2665 2674.
21. Papachroni K., Ninkina N., Wanless J., Kalofoutis A. T., Gnuchev N. V. Buchman V. L. (2005) Peripheral sensory neurons survive in the absence of alpha and gamma synucleins. J. Mol. Neurosci. 25, 157 164.
22. Racke M. K., Ratts R. B., Arredondo L., Perrin P. J. Lovett-Racke A. (2000) The role of costimulation in autoimmune demyelination. J. Neuroimmunol. 107, 205 215.
23. Ringheim G. E. Conant K. (2004) Neurodegenerative disease and the neuroimmune axis (Alzheimer's and Parkinson's disease and viral infections). J. Neuroimmunol. 147, 43 49.
24. Rowe D. B., Le W., Smith R. G. Appel S. H. (1998) Antibodies from patients with Parkinson's disease react with protein modified by dopamine oxidation. J. Neurosci. Res. 53, 551 558.
25. Shavali S., Combs C. K. Ebadi M. (2006) Reactive macrophages increase oxidative stress and alpha-synuclein nitration during death of dopaminergic neuronal cells in co-culture: relevance to Parkinson's disease. Neurochem. Res. 31, 85 94.
26. Terryberry J. W., Thor G. Peter J. B. (1998) Autoantibodies in neurodegenerative diseases: antigen-specific frequencies and intrathecal analysis. Neurobiol. Aging 19, 205 216.
27. Wucherpfennig K. W. (1994) Autoimmunity in the central nervous system: mechanisms of antigen presentation and recognition. Clin. Immunol. Immunopathol. 72, 293 306.
28. Xiromerisiou G., Hadjigeorgiou G. M., Gourbali V., Johnson J., Papakonstantinou I., Papadimitriou A. Singleton A. B. (2006) Screening for SNCA and LRRK2 mutations in Greek sporadic and autosomal dominant Parkinson's disease: identification of two novel LRRK2 variants. Eur. J. Neurol., published online September 21 2006, doi:.
29. Zhang W., Wang T., Pei Z. et al. (2005) Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J. 19, 533 542.